Keyphrases
5′-untranslated Region (5′-UTR)
20%
Alpha-synuclein (α-syn)
100%
Animal Model Study
20%
Blood-brain Barrier
20%
Cell Biology
20%
Cell-based
20%
Chemotype
20%
CNS Drugs
20%
CNS MPO
20%
Cytoprotection
20%
Dementia with
20%
Disabling Conditions
20%
Disease-modifying Strategies
20%
Diverse Scaffolds
20%
Driven Approach
20%
Drug Development
20%
Drug Discovery
20%
Early Parkinson's Disease
20%
Gene Locus
20%
Human Genetics
20%
IND-enabling Study
20%
Neurodegeneration
20%
Neurotherapeutics
20%
Parkinson Patients
20%
Parkinson's Disease
100%
Parkinson's Disease Dementia
20%
Pathogenic Mechanism
20%
Pathologic
20%
Patient-derived Cell Line
20%
Penetrance
20%
Phase 1 Clinical Trial
20%
Progressive Conditions
20%
Proof of Mechanism
20%
Protein Expression
20%
Protein Level
40%
Proteome-wide
20%
Regulatory Elements
20%
RNA-targeted Drug Discovery
100%
Rule of 5
20%
Screening Funnel
20%
Small Interfering RNA (siRNA)
20%
Small Molecules
40%
SNCA Gene
20%
Steady State
20%
Structure Structure
20%
Structure-activity
20%
Structure-property Relationships
20%
Target Validation
20%
Targeted Drug Development
100%
Transcriptome
20%
Transcriptome-wide
20%
Medicine and Dentistry
Biological Product
20%
Blood Brain Barrier
20%
Clinical Trial
20%
Cytoprotection
20%
Cytotechnology
20%
Diseases
60%
Fibril
20%
Gene Locus
20%
Human Genetics
20%
In Vitro
40%
Neurodegeneration
20%
Parkinson's Disease
100%
Penetrance
20%
Protein Expression
20%
Proteome
20%
Small Interfering RNA
20%
Steady State
20%
Synuclein
100%
Transcriptome
40%
Untranslated Region
20%
Vision Screening
20%
Biochemistry, Genetics and Molecular Biology
Animal Model
20%
Blood Brain Barrier
20%
Cell Protection
20%
Clinical Trial
20%
Gene Locus
20%
Human Genetics
20%
Penetrance
20%
Protein Expression
20%
Proteome
20%
Regulatory Element
20%
RNA
100%
Small Interfering RNA
20%
Small Molecule
40%
Steady State
20%
Synuclein
100%
Transcriptome
40%
Untranslated Region
20%